Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
A multicenter phase II study incorporating high-dose rituximab and liposomal doxorubicin into the CODOX-M/IVAC regimen for untreated Burkitt's lymphoma. [electronic resource] by
- Evens, A M
- Carson, K R
- Kolesar, J
- Nabhan, C
- Helenowski, I
- Islam, N
- Jovanovic, B
- Barr, P M
- Caimi, P F
- Gregory, S A
- Gordon, L I
Producer: 20140707
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 24
Availability: No items available.
|
|
6.
|
Corrections to "A multicenter phase II study incorporating high-dose rituximab and liposomal doxorubicin into the CODOX-M/IVAC regimen for untreated Burkitt's lymphoma". [electronic resource] by
- Evens, A M
- Carson, K R
- Kolesar, J
- Nabhan, C
- Helenowski, I
- Islam, N
- Jovanovic, B
- Barr, P M
- Caimi, P F
- Gregory, S A
- Gordon, L I
Publication details: Annals of oncology : official journal of the European Society for Medical Oncology 07 2014
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 25
Availability: No items available.
|